Latest News

Faith and positivity - those are the things that have kept Cynthia Waddy going through the ups and downs of lung cancer treatment.

The American Cancer Society awarded Hollings researcher David Long, Ph.D., a Catalyst grant to study how two proteins' interaction affects genomic instability.

Anti-malarial drug shows promise against cancer, but resistance often develops. A Hollings team found out how, setting stage for combination therapies.

Not enough people are aware of lung cancer screening, even though the test can find early-stage, treatable cancer, Hollings researchers find.

"If you have life, you have hope," explains lung cancer survivor Juan Ramonell.

Quitting smoking soon after a cancer diagnosis adds an average of two years to a patient's life, a new study finds.

Mourning the loss of their wife and mother to astrocytoma, the Kopniskys have donated to research on brain tumors and are sponsors of LOWVELO.

A new study from MUSC Hollings Cancer Center shows how a receptor called PPAR δ helps disable the immune system so that T-cells can’t kill cancer cells.

After twice surviving cancer, an internal medicine resident feels called to oncology.

Admittedly a few years late for her first mammogram, Kristie Rasheed was shocked by a breast cancer diagnosis. Now she encourages others to get screened.